University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children

Phase 1

Completed

Conditions: Caries, Dental
Oral Hygiene
Plaque, Dental

Interventions: Drug: Livionex Dental Gel
Drug: A standard children's toothpaste containing 1500 ppm fluoride

First Posted Date: 2020-04-29

Last Posted Date: 2024-10-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 78

Registration Number: NCT04368533

Locations: 🇺🇸
UCSF Pediatric Dentistry Parnassus Clinic, San Francisco, California, United States

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

Recruiting

Conditions: COVID

First Posted Date: 2020-04-24

Last Posted Date: 2024-05-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 800

Registration Number: NCT04362150

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital (ZSFG), San Francisco, California, United States

SCOPE Analytic Treatment Interruption Protocol

Not Applicable

Recruiting

Conditions: HIV/AIDS

Interventions: Other: Treatment Interruption Arm

First Posted Date: 2020-04-24

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT04359186

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Combinatorial Therapy to Induce an HIV Remission

Phase 1

Active, not recruiting

Conditions: HIV/AIDS

Interventions: Drug: Combination Intervention

First Posted Date: 2020-04-22

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT04357821

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States

Neonatal Seizure Registry - Developmental Functional EValuation

Active, not recruiting

Conditions: Epilepsy
Cerebral Palsy
Stroke
Neonatal Seizure
Intracranial Hemorrhages
Hypoxic-Ischemic Encephalopathy
Intellectual Disability

First Posted Date: 2020-04-08

Last Posted Date: 2024-12-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 280

Registration Number: NCT04337697

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 6 locations

SCOPE-Chinese Women Study

Not Applicable

Completed

Conditions: Obesity, Abdominal
Cancer, Breast

Interventions: Other: SCOPE-Chinese Women

First Posted Date: 2020-03-30

Last Posted Date: 2022-12-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT04326660

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇨🇳
Central South University, Yuelu, Changsha, Hunan, China

COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

Completed

Conditions: Coronavirus
Pregnancy
COVID-19

Interventions: Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19
Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19

First Posted Date: 2020-03-27

Last Posted Date: 2024-05-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1333

Registration Number: NCT04323839

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Identification of Microbial DNA in Maternal Plasma After PPROM

Completed

Conditions: Preterm Rupture of Membranes

Interventions: Diagnostic Test: mNGS

First Posted Date: 2020-03-24

Last Posted Date: 2023-04-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT04318470

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Gut and Azithromycin Mechanisms in Infants and Children II

Phase 4

Completed

Conditions: Malaria

Interventions: Drug: Placebo
Drug: Azithromycin

First Posted Date: 2020-03-19

Last Posted Date: 2023-06-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 449

Registration Number: NCT04315272

Locations: 🇧🇫
Centre de Recherche en santé de nouna, Nouna, Boucle Du Mouhoun, Burkina Faso

Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine

Not Applicable

Active, not recruiting

Conditions: Rheumatic Diseases

Interventions: Other: New e-prescribing interface

First Posted Date: 2020-03-17

Last Posted Date: 2023-07-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 65

Registration Number: NCT04310462

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy